Cargando…

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies

Recent outbreaks of yellow fever virus (YFV) in West Africa and Brazil resulted in rapid depletion of global vaccine emergency stockpiles and raised concerns about being unprepared against future YFV epidemics. Here we report that a live attenuated virus similar to the Japanese encephalitis virus (J...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mishra, Niraj, Boudewijns, Robbert, Schmid, Michael Alexander, Marques, Rafael Elias, Sharma, Sapna, Neyts, Johan, Dallmeier, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157777/ https://www.ncbi.nlm.nih.gov/pubmed/32265332 http://dx.doi.org/10.1128/mBio.02494-19

Ejemplares similares

A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice
por: Kum, Dieudonné Buh, et al.
Publicado: (2020)

A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
por: Kum, Dieudonné B., et al.
Publicado: (2018)

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice
por: Ma, Ji, et al.
Publicado: (2021)

A High-Throughput Yellow Fever Neutralization Assay
por: Rasulova, Madina, et al.
Publicado: (2022)

A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice
por: Boudewijns, Robbert, et al.
Publicado: (2021)

Limited evolution of the yellow fever virus 17d in a mouse infection model
por: Kum, Dieudonné Buh, et al.
Publicado: (2019)

Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine
por: Sharma, Sapna, et al.
Publicado: (2020)

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
por: Lemmens, Viktor, et al.
Publicado: (2023)

Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection
por: Ricciardi, Michael J., et al.
Publicado: (2023)

Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models
por: Ma, Ji, et al.
Publicado: (2022)

Lethal Encephalitis in Seals with Japanese Encephalitis Virus Infection, China, 2017
por: Li, Xiangdong, et al.
Publicado: (2019)

A rat model for hepatitis E virus
por: Debing, Yannick, et al.
Publicado: (2016)

A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses
por: Oreshkova, Nadia, et al.
Publicado: (2021)

Novel synthetic nucleotides of notifiable dengue (1–4), Japanese encephalitis, yellow fever and Zika flaviviruses
por: Camer, Gerry Amor, et al.
Publicado: (2018)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
por: Garg, Himanshu, et al.
Publicado: (2020)

Diagnostic Specificity of Two Dengue Virus IgG ELISAs after Yellow Fever and Japanese Encephalitis Virus Vaccination
por: Schnabel, Isabelle, et al.
Publicado: (2022)

Japanese spotted fever with post-infectious encephalitis
por: Wada, Takafumi, et al.
Publicado: (2022)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
por: Bouckenooghe, Alain, et al.
Publicado: (2018)

A Human/Murine Chimeric Fab Antibody Neutralizes Anthrax Lethal Toxin In Vitro
por: Ding, Guipeng, et al.
Publicado: (2013)

Simple and inexpensive three-step rapid amplification of cDNA 5′ ends using 5′ phosphorylated primers
por: Dallmeier, Kai, et al.
Publicado: (2013)

Zika and Other Emerging Viruses: Aiming at the Right Target
por: Dallmeier, Kai, et al.
Publicado: (2016)

CLEC5A Regulates Japanese Encephalitis Virus-Induced Neuroinflammation and Lethality
por: Chen, Szu-Ting, et al.
Publicado: (2012)

A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine
por: Yan, Kexin, et al.
Publicado: (2020)

IMMUNITY TO YELLOW FEVER ENCEPHALITIS OF MONKEYS AND MICE IMMUNIZED BY NEURAL AND EXTRANEURAL ROUTES
por: Fox, John P.
Publicado: (1943)

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial
por: Sandberg, John Tyler, et al.
Publicado: (2023)

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice
por: Fang, Enyue, et al.
Publicado: (2022)

Synthesis and evaluation of imidazole-4,5- and pyrazine-2,3-dicarboxamides targeting dengue and yellow fever virus()
por: Saudi, Milind, et al.
Publicado: (2014)

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2021)

Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model
por: Caroline, Amy L., et al.
Publicado: (2016)

Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus()
por: Saudi, Milind, et al.
Publicado: (2016)

Flaviviral NS4b, chameleon and jack‐in‐the‐box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention
por: Zmurko, Joanna, et al.
Publicado: (2015)

COVID-19 and the intensive care unit: vaccines to the rescue
por: Dallmeier, Kai, et al.
Publicado: (2021)

Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
por: Miyaji, Karina Takesaki, et al.
Publicado: (2017)

A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus
por: Li, Yan, et al.
Publicado: (2022)

Isolation and Chimerization of a Highly Neutralizing Antibody Conferring Passive Protection against Lethal Bacillus anthracis Infection
por: Rosenfeld, Ronit, et al.
Publicado: (2009)

Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus
por: Kuznetsova, Nadezhda, et al.
Publicado: (2023)

Dengue Hemorrhagic Fever in a Japanese Traveler with Pre-existing Japanese Encephalitis Virus Antibody
por: Sato, Rumi, et al.
Publicado: (2015)

Generation and characterization of chimeric Tembusu viruses containing pre-membrane and envelope genes of Japanese encephalitis virus
por: Xu, Bangfeng, et al.
Publicado: (2023)

Yellow Fever
Publicado: (1898)

Cannot write session to /tmp/vufind_sessions/sess_qpkipq4l6gf7rjo8l5s2b5lg88